Literature DB >> 2463631

Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells.

G Pecoraro1, D Morgan, V Defendi.   

Abstract

The human papillomaviruses (HPVs) are associated with specific benign and malignant lesions of the skin and mucosal epithelia. Cloned viral DNAs from HPV types 6b, 16, and 18 associated with different pathological manifestations of genital neoplasia in vivo were introduced into primary human cervical epithelial cells by electroporation. Cells transfected with HPV16 or HPV18 DNA acquired indefinite lifespans, distinct morphological alterations, and anchorage-independent growth (HPV18), and contain integrated transcriptionally active viral genomes. HPV6b or plasmid electroporated cells senesced at low passage. The alterations in growth and differentiation of the cells appear to reflect the progressive oncogenic processes that result in cervical carcinoma in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463631      PMCID: PMC286512          DOI: 10.1073/pnas.86.2.563

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  VARIATIONS IN THE MORPHOGENESIS OF SQUAMOUS CARCINOMA OF THE CERVIX.

Authors:  R BANGLE; M BERGER; M LEVIN
Journal:  Cancer       Date:  1963-09       Impact factor: 6.860

2.  Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization.

Authors:  T Tase; T Okagaki; B A Clark; D A Manias; R S Ostrow; L B Twiggs; A J Faras
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

3.  Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells.

Authors:  T Kanda; A Furuno; K Yoshiike
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA.

Authors:  C D Woodworth; P E Bowden; J Doniger; L Pirisi; W Barnes; W D Lancaster; J A DiPaolo
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

5.  Isolation of a novel human papillomavirus (type 51) from a cervical condyloma.

Authors:  G J Nuovo; C P Crum; E M De Villiers; R U Levine; S J Silverstein
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

6.  Transformation of C127 mouse fibroblasts by human papillomavirus 16.

Authors:  D Morgan; G Pecoraro; I Rosenberg; V Defendi
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

7.  Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA.

Authors:  M Dürst; R T Dzarlieva-Petrusevska; P Boukamp; N E Fusenig; L Gissmann
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

8.  Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter.

Authors:  T Kanda; S Watanabe; K Yoshiike
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

9.  Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA.

Authors:  L Pirisi; S Yasumoto; M Feller; J Doniger; J A DiPaolo
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

10.  Comparison of the in vitro transforming activities of human papillomavirus types.

Authors:  A Storey; D Pim; A Murray; K Osborn; L Banks; L Crawford
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  42 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 2.  So Now My Patient Has Squamous Cell Cancer: Diagnosis, Staging, and Treatment of Squamous Cell Carcinoma of the Anal Canal and Anal Margin.

Authors:  Cindy Kin
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

3.  Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture.

Authors:  R A Blanton; N Perez-Reyes; D T Merrick; J K McDougall
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

4.  Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells.

Authors:  G Pecoraro; M Lee; D Morgan; V Defendi
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

5.  Malignant transformation of human keratinocytes during adaptation to autotrophy.

Authors:  M Hill; J Hillova; R Mariage-Samson
Journal:  In Vitro Cell Dev Biol       Date:  1991-04

6.  In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential.

Authors:  M S Barbosa; W C Vass; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells.

Authors:  C L Halbert; G W Demers; D A Galloway
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines.

Authors:  M Dürst; F X Bosch; D Glitz; A Schneider; H zur Hausen
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype.

Authors:  P J Hurlin; P Kaur; P P Smith; N Perez-Reyes; R A Blanton; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 10.  A possible role for human papillomaviruses in head and neck cancer.

Authors:  B M Steinberg; T P DiLorenzo
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.